Visceral obesity may affect oncologic outcome in patients with colorectal cancer

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1918-1922

  Moon, Hyeong Gon ^a,b   Ju, Young Tae ^a,b   Jeong, Chi Young ^a,b   Jung, Eun Jung ^a,b   Lee, Young Joon ^a,b   Hong, Soon Chan ^a,b   Ha, Woo Song ^a,b   Park, Soon Tae ^a,b   Choi, Sang Kyung ^a,b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongnam Regional Cardiocerebrovascular Disease Center   (South Korea)

Author keywords

Colorectal cancer; Obesity; Prognosis; Recurrence; Visceral obesity

Indexed keywords

ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PROGNOSIS; SUBCUTANEOUS FAT; VISCERAL OBESITY;

ADIPOSITY; AGED; BODY MASS INDEX; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46149121260     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9891-4     Document Type: Article

References (19)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-7.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-28.
3. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4:579-91.
4. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002; 3:565-74.
5. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-38.
6. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91:1147-54.
7. Murphy TK, Calle EE, Rodriguez C, et al. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000; 152:847-54.
8. IARC. Weight control and physical activityed. Lyon: IARC; Oxford: Oxford University Press [distributor], 2002
9. Karelis AD, St-Pierre DH, Conus F, et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89:2569-75.
10. Otake S, Takeda H, Suzuki Y, et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005; 11:3642-6.
11. Cowey SL, Quast M, Belalcazar LM, et al. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 2005; 103:2643-53.
12. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002; 20:1128-43.
13. Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004; 15:875-84.
14. Tartter PI, Slater G, Papatestas AE, et al. Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence. J Surg Oncol 1984; 27:232-5.
15. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98:484-95.
16. Warren M, Schreiner PJ, Terry JG. The relation between visceral fat measurement and torso level-is one level better than another? The Atherosclerosis Risk in Communities Study, 1990-1992. Am J Epidemiol 2006; 163:352.
17. Giovannucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995; 122:327-34.
18. Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003; 26:2341-4.
19. Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500:88-96.